Allergan Discusses Shareholder Requests in Takeover Bid

Aug 26, 2014

Boston Herald

Allergan Inc. is said to be reviewing shareholder requests for a special meeting to consider replacing most of its board, a change Valeant Pharmaceuticals International is seeking as part of its hostile takeover attempt, according to an article in the Boston Herald.

Valeant and its partner — Pershing Square Capital Management LP — said they had submitted to Allergan written requests for a special shareholders meeting from holders of 31 percent of Allergan's stock. That exceeds the level Allergan's bylaws require, Pershing Square said. Read the full article

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments